Clinical Trials Directory

Trials / Terminated

TerminatedNCT02177526

Imaging of High Grade Prostate Cancer

Detection of Malignant Calcifications in High Grade Prostate Cancer With Comedo-type Necrosis Using Thin Section Computed Tomography and Susceptibility Weighted Magnetic Resonance Imaging

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Ottawa Hospital Research Institute · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

Management of prostatic carcinoma varies according to stage of disease. Trans-rectal ultrasound guided biopsy is known to underestimate the degree of tumor due to undersampling and random non-targeted technique. Methods to improve pre-operative tumor localization and grading, including multi-parametric (MP) magnetic resonance imaging (MRI) is an active area of research but requires further validation. High grade tumors can undergo comedo-type necrosis with malignant calcifications which only occurs in Gleason pattern 5 tumors and which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI. Detection of malignant calcification within tumor foci will improve the accuracy of localization and grading in prostatic carcinoma.

Detailed description

High grade (Gleason pattern 5) tumors can undergo comedo-type necrosis producing malignant calcifications which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI. Detection of malignant calcifications in areas of Gleason pattern 5 tumor will improve the accuracy of pre-operative localization and grading in prostatic carcinoma.

Conditions

Interventions

TypeNameDescription
DEVICEImaging15 patients with malignant comedo-type necrosis and calcifications detected with histo-pathology from guided biopsies will be enrolled after obtaining informed consent. 15 patients with biopsy proven Gleason pattern 5 tumor and without comedo-type necrosis associated calcification will serve as a comparison group after providing informed consent for a total of 30 patients.

Timeline

Start date
2014-06-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2014-06-27
Last updated
2015-11-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02177526. Inclusion in this directory is not an endorsement.